Mankind Pharma has officially completed the amalgamation of three of its subsidiaries—Shree Jee Laboratory Private Limited, JPR Labs Private Limited, and Jaspack Industries Private Limited—into the company, effective March 29, 2025.

The move follows the approval from the National Company Law Tribunal (NCLT), New Delhi Bench, which sanctioned the Scheme of Arrangement under the Companies Act, 2013. The certified order was received on March 12, 2025, and the effective date of the merger was confirmed after filing E-Form INC-28 with the Registrar of Companies (ROC).

With this consolidation, the assets and liabilities of the three transferor companies now stand transferred to Mankind Pharma, and the subsidiaries are dissolved without undergoing liquidation. Additionally, the company’s authorised share capital has been adjusted to ₹421.51 crore, incorporating the share capital of the merged entities.

On Friday, March 28, the company received approval from NCLT, Mumbai bench, for the merger of its material subsidiary BSV Pharma Private Limited with Bharat Serums and Vaccines Limited (BSV). BSV Pharma is engaged in the marketing, distribution, procurement, and sale of women’s healthcare products in India.

The shares Mankind Pharma closed at ₹2,423.60 apiece on Friday, reflecting a 1.16% decline. Despite the dip, the stock has gained 5.34% over the past year.

Also Read: Adani Green Energy arm begins operating new solar power project in Khavda, Gujarat